Cancer charities join forces for ‘20 for 20’ fundraising campaign

A group of 20 cancer charities have linked up for a fundraising campaign to help them tackle the “devastating disruption” to their services supporting patients with rare forms of cancer amid the Covid-19 pandemic.

The initiative is called ’20 for 20’ and has been inspired by collaborative fundraising that took place during the 2.6 challenge, which replaced the London Marathon earlier this year with alternative activities.

The 20 for 20 campaign has been organised by bone and tissue cancer charity Sacoma UK.

Other charities involved include Target Ovarian Cancer, Cancer52, blood cancer charity DKMS and Brain Tumour Research.

The fundraising push asks the charities’ supporters to take part in any fundraising challenge based around the number 20 across 20 days. This could be running for 20 minutes a day or baking 20 cakes.

Together the charities involved fund around £6m in cancer research each year.

“For countless patients and their families, the charities taking part in 20 for 20 are a lifeline of support, information, campaigning and are funders of research specifically looking into these cancers,” said Cancer52 chief executive Jane Lyons.

“We risk losing this in the long-term if these charities have to further cut what they can do, or worse still, shut. 20 for 20 is a powerful statement about a unique collaboration to bring in some much-needed income that has been lost due to the

Covid-19 pandemic. As a strong collective voice, we believe we can achieve more together than apart.”

Sarcoma UK chief executive Richard Davidson added: “These cancer charities are needed now more than ever. 20 for 20 is a bold attempt to take control of the situation, not as competitors but as partners to make sure we can continue to be there for patients now and crucially, in the future.”

    Share Story:

Recent Stories


Beyond the funding squeeze: Using equities to secure your charity’s future
With charities facing increasing financial pressure and traditional income streams under strain, making investments work harder has never been more important. M&G’s Richard Macey and Michael Stiasny join Charity Times to discuss why equities remain a vital long-term asset class for charities, how organisations can balance income generation and growth, and the opportunities the current market environment may offer to help strengthen financial resilience.

Charity Times Awards 2023

Charity Times video Q&A: In conversation with Hilda Hayo, CEO of Dementia UK
Charity Times editor, Lauren Weymouth, is joined by Dementia UK CEO, Hilda Hayo to discuss why the charity receives such high workplace satisfaction results, what a positive working culture looks like and the importance of lived experience among staff. The pair talk about challenges facing the charity, the impact felt by the pandemic and how it's striving to overcome obstacles and continue to be a highly impactful organisation for anybody affected by dementia.